BIO-USAWA

Do you have an idea for The New Times to cover? Submit it here!
Search Results for "BIO-USAWA" (11 articles)
Dr. Menghis Bairu (L) is President & CEO of biotech company Bio Usawa, whereas Prof. Wanjiku Mathenge (R) is a renowned ophthalmologist in Africa.

Rwanda’s approval of first eye care biosimilar offers hope for millions

Thursday, October 23, 2025
Rwanda has approved BioUcenta™, a lower-cost drug similar to Lucentis® (ranibizumab), to treat diabetic macular edema
Health

Rwanda FDA approves Africa’s first affordable eye drug

Tuesday, October 21, 2025
Dr. Menghis Bairu captures a quiet moment overlooking Lake Kivu during a weekend stay at Cleo Hotel in Western Rwanda

From scenic views to unexpected talent: My weekend at Lake Kivu

Monday, July 28, 2025
A cancer patient undergoes chemotherapy treatment. Studies have revealed that one in five commonly used cancer drugs in LMICs are substandard. Photo by Reuters

Substandard cancer drugs a global scandal and public health emergency for LMICs

Saturday, July 12, 2025
L-R: Menghis Bairu, the President and CEO of Bio Usawa, Delese Mimi Darko, the Managing Director of the African Medicines Agency, and Nicaise Ndembi, the Deputy Director General of the Africa Regional Office of the International Vaccine Institute. All three organizations are headquartered in Kigali.

How Kigali is becoming Africa’s biopharma capital

Saturday, July 05, 2025
BasiGo and AC Mobility aim to deliver 200 electric buses to bus operators in the country Courtesy
Economy

Top investment projects registered in Rwanda in 2024

Monday, April 21, 2025
Rwanda recorded a 32 per cent increase in investment in 2024. File
Economy

Rwanda records 32% rise in investment in 2024

Monday, April 14, 2025
No Image
play icon
Health

Rwanda to host Africa’s first eye and cancer drug facility

Friday, March 14, 2025
Menghis Bairu, the Chief Executive Officer of Bio Usawa and Francis Gatare, Rwanda Development Board's Chief Executive Officer in February 2024. Courtesy
Health

Rwanda, Bio Usawa ink deal to manufacture affordable eye treatments in Africa

Friday, November 22, 2024
UVU Bio, a renowned biotech incubator that runs the recently inaugurated Bioeconomy Hub in Kigali, welcomed its first cohort for a one-month intensive training on biotechnology and laboratory skills in September. Photo by UVU Bio

To shape Africa’s pharma future, empower a youthful workforce to lead the way

Thursday, October 17, 2024
Rwanda will host the inaugural East Africa Pharma and Biotech Conference in Kigali on September 17-19, 2024. The country is also home to Africa's first mRNA vaccine plant.

Time is Now: Africa’s quest to become a global biomedicine hub

Monday, September 16, 2024